Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:18 pm Sale | 2024-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | ARMISTICE CAPITAL LLC | 1,152,000 6.540% | -384,000 (-25.00%) | Filing History |
| 2025-02-11 4:00 pm Purchase | 2024-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | SOLEUS CAPITAL MASTER FUND, L.P. | 1,130,679 6.400% | 195,891 (+20.96%) | Filing History |
| 2025-02-07 1:42 pm Sale | 2024-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | Invesco Ltd. IVZ | 6,449 0.000% | -1,044,906 (-99.39%) | Filing History |
| 2025-02-05 1:23 pm Purchase | 2024-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | BlackRock Inc. BLK | 1,748,107 9.900% | 1,748,107 (New Position) | Filing History |
| 2024-11-14 5:18 pm Purchase | 2024-09-30 | 13G | Rigel Pharmaceuticals, Inc. RIGL | ARMISTICE CAPITAL LLC | 1,536,000 8.730% | 1,536,000 (New Position) | Filing History |
| 2024-11-14 3:33 pm Purchase | 2024-09-30 | 13G | Rigel Pharmaceuticals, Inc. RIGL | SOLEUS CAPITAL MASTER FUND, L.P. | 934,788 5.300% | 934,788 (New Position) | Filing History |
| 2024-11-08 09:33 am Purchase | 2024-11-08 | 13G | Rigel Pharmaceuticals, Inc. RIGL | Invesco Ltd. IVZ | 1,051,355 6.000% | 1,051,355 (New Position) | Filing History |
| 2024-02-14 2:30 pm Purchase | 2023-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | ARMISTICE CAPITAL LLC | 1,710,000 9.810% | 14,400 (+0.85%) | Filing History |
| 2024-02-13 5:13 pm Sale | 2023-12-29 | 13G | Rigel Pharmaceuticals, Inc. RIGL | The Vanguard Group | 895,322 5.130% | -313,058 (-25.91%) | Filing History |
| 2024-02-09 12:17 pm Purchase | 2023-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | MORGAN STANLEY MS | 1,449,060 8.300% | 1,449,060 (New Position) | Filing History |
| 2024-02-05 5:34 pm Sale | 2023-12-29 | 13G | Rigel Pharmaceuticals, Inc. RIGL | GOLDMAN SACHS GROUP INC GS | 25,568 0.100% | -911,439 (-97.27%) | Filing History |
| 2024-02-02 09:56 am Purchase | 2023-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | SOLEUS CAPITAL MASTER FUND, L.P. | 944,258 5.400% | 21,956 (+2.38%) | Filing History |
| 2024-01-25 1:48 pm Purchase | 2023-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | BlackRock Inc. BLK | 1,519,808 8.700% | 51,701 (+3.52%) | Filing History |
| 2023-06-12 08:21 am Sale | 2023-06-09 | 13G | Rigel Pharmaceuticals, Inc. RIGL | FMR LLC | 20,082 0.115% | -869,119 (-97.74%) | Filing History |
| 2023-02-22 4:03 pm Purchase | 2023-02-21 | 13G | Rigel Pharmaceuticals, Inc. RIGL | SOLEUS CAPITAL MASTER FUND, L.P. | 922,302 5.300% | 922,302 (New Position) | Filing History |
| 2023-02-14 2:40 pm Purchase | 2022-12-30 | 13G | Rigel Pharmaceuticals, Inc. RIGL | GOLDMAN SACHS GROUP INC GS | 937,006 5.400% | 937,006 (New Position) | Filing History |
| 2023-02-14 1:21 pm Purchase | 2022-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | ARMISTICE CAPITAL LLC | 1,695,600 9.810% | 1,695,600 (New Position) | Filing History |
| 2023-02-09 12:31 pm Sale | 2023-02-09 | 13G | Rigel Pharmaceuticals, Inc. RIGL | FMR LLC | 889,201 5.144% | -659,458 (-42.58%) | Filing History |
| 2023-02-09 11:30 am Purchase | 2022-12-30 | 13G | Rigel Pharmaceuticals, Inc. RIGL | The Vanguard Group | 1,208,380 6.990% | 305,568 (+33.85%) | Filing History |
| 2023-02-06 1:20 pm Sale | 2022-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | STATE STREET CORP STT | 337,491 1.950% | -50,315 (-12.97%) | Filing History |